Your browser doesn't support javascript.
loading
Metabolic activation of WHO-congeners PCB28, 52, and 101 by human CYP2A6: evidence from in vitro and in vivo experiments.
Randerath, Isabella; Schettgen, Thomas; Müller, Julian Peter; Rengelshausen, Jens; Ziegler, Susanne; Quinete, Nathalia; Bertram, Jens; Laieb, Salah; Schaeffeler, Elke; Kaifie, Andrea; Just, Katja S; Voigt, Aaron; Tremmel, Roman; Schwab, Matthias; Stingl, Julia C; Kraus, Thomas; Ziegler, Patrick.
Afiliación
  • Randerath I; Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.
  • Schettgen T; Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.
  • Müller JP; Institute of Clinical Pharmacology, University Hospital of RWTH, 52074, Aachen, Germany.
  • Rengelshausen J; Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.
  • Ziegler S; Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany.
  • Quinete N; Department of Chemistry and Biochemistry, Institute of Environment, Florida International University, 3000 NE 151s Street, North Miami, FL, 33181, USA.
  • Bertram J; Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.
  • Laieb S; Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.
  • Schaeffeler E; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tübingen, Germany.
  • Kaifie A; Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.
  • Just KS; Institute of Clinical Pharmacology, University Hospital of RWTH, 52074, Aachen, Germany.
  • Voigt A; Department of Neurology, University Medical Center, RWTH Aachen University, 52074, Aachen, Germany.
  • Tremmel R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tübingen, Germany.
  • Schwab M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tübingen, Germany.
  • Stingl JC; Departments of Clinical Pharmacology, and Pharmacy and Biochemistry, University of Tuebingen, Tübingen, Germany.
  • Kraus T; Institute of Clinical Pharmacology, University Hospital of RWTH, 52074, Aachen, Germany.
  • Ziegler P; Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.
Arch Toxicol ; 2024 Aug 13.
Article en En | MEDLINE | ID: mdl-39136732
ABSTRACT
Despite extensive research on the metabolism of polychlorinated biphenyls (PCBs), knowledge gaps persist regarding their isoform-specific biotransformation pathways. This study aimed to elucidate the role of different cytochrome P450 enzymes in PCB metabolism, focusing on WHO-congeners 2,4,4'-trichlorobiphenyl (PCB28), 2,2',5,5'-tetrachlorobiphenyl (PCB52), and 2,2',4,5,5'-pentachlorobiphenyl (PCB101). Utilizing engineered HEK293 cell lines, we investigated the in vitro metabolism of these PCBs by CYP1A2, CYP2C8, CYP2C9, CYP3A4, CYP2A6, and CYP2E1, revealing robust production of hydroxylated metabolites. Our results show that CYP2A6 plays a major role in the metabolism of these congeners responsible for predominant formation of para-position hydroxylated metabolites, with concentrations reaching up to 1.61 µg/L (5,89 nM) for PCB28, 316.98 µg/L (1,03 µM) for PCB52, and 151.1 µg/L (441 nM) for PCB101 from a 20 µM parent PCB concentration. Moreover, concentration-dependent cytotoxic and cytostatic effects induced by reactive intermediates of the PCB hydroxylation pathway were observed in HEK293CYP2A6 cells, for all three congeners tested. CYP2A6 was specifically capable of activating PCBs 28 and 101 to genotoxic metabolites which produced genetic defects which were propagated to subsequent generations, potentially contributing to carcinogenesis. In a clinical study examining CYP2A6 enzyme activity in formerly exposed individuals with elevated internal PCB levels, a participant with increased enzyme activity showed a direct association between the phenotypic activity of CYP2A6 and the metabolism of PCB28, confirming the role of CYP2A6 in the in vivo metabolism of PCB28 also in humans. These results altogether reinforce the concept that CYP2A6 plays a pivotal role in PCB congener metabolism and suggest its significance in human health, particularly in the metabolism of lower chlorinated, volatile PCB congeners.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Arch Toxicol Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Arch Toxicol Año: 2024 Tipo del documento: Article País de afiliación: Alemania